NCT00431340View on ClinicalTrials.gov

A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Multiple Myeloma
Interventions
DRUG

PXD101

Trial Locations (3)

20817

Center for cancer and blood disorders, Bethesda

75246

Baylor University Medical Center, Dallas

90069

Oncotherapeutics, West Hollywood

Sponsors
All Listed Sponsors
lead

Valerio Therapeutics

INDUSTRY